News and Events

Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering

Recent publications, including a landmark paper from Novartis¹, demonstrate the viability and utility of cryopreserved leukopaks, dispelling the viability myth.

Cryopreserved leukopaks eliminate the constraints imposed by a reliance on fresh human cells for T-cell therapies. Has the tide turned in favor of frozen cells?

Dr. Albert Li presents Discovery Life Science’s Hepatocyte and Enterocyte products. In this presentation, Dr. Li discusses the technology, applications, and advantages of Discovery’s ADMET products.